triazolam and Acute Disease studies

triazolam and Acute Disease

triazolam has been researched along with Acute Disease in 3 studies

Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.

Acute Disease: Disease having a short and relatively severe course.

Research Excerpts

Excerpt	Relevance	Reference
"Triazolam was chosen as the reference compound because it binds nonselectively to BZ1 and BZ2 benzodiazepine-receptor subtypes."	2.69	Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects. ( Ali, JA; Armstrong, DL; Pazzaglia, PJ; Rush, CR, 1998)
"Rebound insomnia, a worsening of sleep compared with baseline, occurred following withdrawal of triazolam, nitrazepam, and flunitrazepam after they had been given in only single, nightly doses for short periods."	1.26	Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines. ( Kales, A; Kales, JD; Scharf, MB; Soldatos, CR, 1979)

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

1 (33.33)

18.7374

1990's

2 (66.67)

18.2507

2000's

0 (0.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Rush, CR	1
Armstrong, DL	1
Ali, JA	1
Pazzaglia, PJ	1
Kales, A	1
Scharf, MB	1
Kales, JD	1
Soldatos, CR	1
Strohmaier, A	1
Friedrich, M	1

Studies

Rush, CR

Armstrong, DL

Ali, JA

Pazzaglia, PJ

Kales, A

Scharf, MB

Kales, JD

Soldatos, CR

Strohmaier, A

Friedrich, M

Trials

1 trial available for triazolam and Acute Disease

Article	Year
Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects. Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:2 Topics: Acute Disease; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Fem	1998

Article

Year

Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects.

Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:2

Topics: Acute Disease; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Fem

1998

Other Studies

2 other studies available for triazolam and Acute Disease

Article	Year
Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines. JAMA, 1979, Apr-20, Volume: 241, Issue:16 Topics: Acute Disease; Benzodiazepines; Flunitrazepam; Half-Life; Humans; Nitrazepam; Sleep Initiation and M	1979
[A nontraumatic compartment syndrome of both lower legs resulting from acute rhabdomyolysis]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1991, Volume: 155, Issue:3 Topics: Acute Disease; Adolescent; Alcoholic Intoxication; Compartment Syndromes; Drug Overdose; Fasciotomy;	1991

Article

Year

Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.

JAMA, 1979, Apr-20, Volume: 241, Issue:16

Topics: Acute Disease; Benzodiazepines; Flunitrazepam; Half-Life; Humans; Nitrazepam; Sleep Initiation and M

1979

[A nontraumatic compartment syndrome of both lower legs resulting from acute rhabdomyolysis].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1991, Volume: 155, Issue:3

Topics: Acute Disease; Adolescent; Alcoholic Intoxication; Compartment Syndromes; Drug Overdose; Fasciotomy;

1991